GR1000716B - Υποκαταστημενες 2-ιμιδαζολινες και παρασκευη και χρηση αυτων. - Google Patents

Υποκαταστημενες 2-ιμιδαζολινες και παρασκευη και χρηση αυτων.

Info

Publication number
GR1000716B
GR1000716B GR900100535A GR900100535A GR1000716B GR 1000716 B GR1000716 B GR 1000716B GR 900100535 A GR900100535 A GR 900100535A GR 900100535 A GR900100535 A GR 900100535A GR 1000716 B GR1000716 B GR 1000716B
Authority
GR
Greece
Prior art keywords
pct
imidazolines
preparation
substituted
sec
Prior art date
Application number
GR900100535A
Other languages
English (en)
Other versions
GR900100535A (en
Inventor
Sune Henrik Andersen
Poul Borrevang
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of GR900100535A publication Critical patent/GR900100535A/el
Publication of GR1000716B publication Critical patent/GR1000716B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Nonmetallic Welding Materials (AREA)
  • External Artificial Organs (AREA)
  • Fertilizers (AREA)

Abstract

Ορισμένες 2-(2,2-διαρυλαιθυλ)-2-ιμιδαζολίνες έχουν μια πτωτική δράση στην γλυκόζη του αίματος σε θηλαστικά. ω
GR900100535A 1989-07-12 1990-07-12 Υποκαταστημενες 2-ιμιδαζολινες και παρασκευη και χρηση αυτων. GR1000716B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK344489A DK344489D0 (da) 1989-07-12 1989-07-12 Substituerede 2-imidazoliner og fremstilling og anvendelse deraf

Publications (2)

Publication Number Publication Date
GR900100535A GR900100535A (en) 1991-12-10
GR1000716B true GR1000716B (el) 1992-11-23

Family

ID=8122944

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100535A GR1000716B (el) 1989-07-12 1990-07-12 Υποκαταστημενες 2-ιμιδαζολινες και παρασκευη και χρηση αυτων.

Country Status (22)

Country Link
US (1) US5262430A (el)
EP (1) EP0482108B1 (el)
JP (1) JPH04506968A (el)
KR (1) KR927003578A (el)
CN (1) CN1049343A (el)
AT (1) ATE135703T1 (el)
AU (1) AU637393B2 (el)
CA (1) CA2064095A1 (el)
DD (1) DD296489A5 (el)
DE (1) DE69026087T2 (el)
DK (2) DK344489D0 (el)
ES (1) ES2086409T3 (el)
FI (1) FI920118A0 (el)
GR (1) GR1000716B (el)
IE (1) IE74210B1 (el)
IL (1) IL95046A (el)
NO (1) NO920143L (el)
NZ (1) NZ234451A (el)
PT (1) PT94685B (el)
WO (1) WO1991000862A1 (el)
YU (1) YU136390A (el)
ZA (1) ZA905422B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4201709A1 (de) * 1992-01-23 1993-07-29 Bayer Ag (alpha)-aryl-(alpha)-hydroxy-ss-imidazolinyl-propionsaeureamide
US5750543A (en) * 1996-02-01 1998-05-12 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US6410562B1 (en) 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds
US20090162342A1 (en) * 2001-06-07 2009-06-25 Sanomune Inc. Therapeutic uses of glandular kallikrein
WO2005118539A1 (en) * 2004-06-01 2005-12-15 F.Hoffmann-La Roche Ag 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
HUE032613T2 (en) 2012-06-04 2017-10-30 Diamedica Therapeutics Inc Human tissue kallikrein 1 is glycosylated isoforms
US11857608B2 (en) 2017-03-09 2024-01-02 Diamedica Inc. Dosage forms of tissue kallikrein 1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936885B2 (ja) * 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤
ZW13782A1 (en) * 1981-07-28 1982-10-06 Reckitt & Colmann Prod Ltd Imidazoline derivatives
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
KR927003578A (ko) 1992-12-18
EP0482108B1 (en) 1996-03-20
DD296489A5 (de) 1991-12-05
DK0482108T3 (da) 1996-07-22
CN1049343A (zh) 1991-02-20
PT94685B (pt) 1997-04-30
AU6164490A (en) 1991-02-06
IL95046A0 (en) 1991-06-10
DE69026087T2 (de) 1996-08-29
GR900100535A (en) 1991-12-10
ZA905422B (en) 1991-03-27
JPH04506968A (ja) 1992-12-03
DE69026087D1 (de) 1996-04-25
ES2086409T3 (es) 1996-07-01
IL95046A (en) 1995-03-15
YU136390A (sh) 1993-10-20
FI920118A0 (fi) 1992-01-10
NO920143L (no) 1992-03-04
IE902546A1 (en) 1991-02-27
CA2064095A1 (en) 1991-01-13
US5262430A (en) 1993-11-16
EP0482108A1 (en) 1992-04-29
AU637393B2 (en) 1993-05-27
NZ234451A (en) 1991-08-27
DK344489D0 (da) 1989-07-12
NO920143D0 (no) 1992-01-10
IE74210B1 (en) 1997-07-16
WO1991000862A1 (en) 1991-01-24
PT94685A (pt) 1991-03-20
ATE135703T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
ATE146360T1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
IE901821L (en) Porous pharmaceutical form
MY105493A (en) Contrast media
ZA905422B (en) Substituted 2-imidazolines and preparation and use thereof
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
DE69022845D1 (en) Erythromycinderivate.
DE69002946D1 (de) Paracetamol enthaltende arzneizubereitung.
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
IT1216139B (it) Composizione dietetica eprocedimento per la sua preparazione.
EP0329043A3 (en) Optically active rhodium-complexes of 3,4-bis(diarylphosphino)-pyrrolidines, and their use in the preparation of phosphinothricine by asymmetric hydrogenation
IL81549A0 (en) Pharmaceutical compositions containing glycerophosphoryl-o-serine or a salt thereof,certain such novel salts and their preparation
EP0234348A3 (en) N-glycosyl amide derivatives, method for their preparation and their use as medicaments
ZA891242B (en) 24r-scymnol,and preparation and use thereof
IL86479A (en) Substituted vinylcephalosporins, their preparation and pharmaceutical compositions containing them
DE3572768D1 (en) Pharmaceutical compositions and their use as mydriatics
IL85508A0 (en) Benzylaminoaryl-dihydropyridinelactones,their preparation and their use in medicaments
Seo Recommendations for the Improvement of the Medical Licensing Examination
TH9036EX (th) ปุ่มควบคุมการทำงาน
IT8819665A0 (it) (1,2_di_0_acetil_glicero_3_fosforil)_colina, procedimento per la sua preparazione e suo uso terapeutico.